{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T11:43:53Z","timestamp":1793187833669,"version":"4.5.0"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100016334","name":"The First Affiliated Hospital with Nanjing Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100016334","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2027,3]]},"DOI":"10.1016\/j.cca.2026.122940","type":"journal-article","created":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T15:45:10Z","timestamp":1792597510000},"page":"122940","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Routine antinuclear antibody testing as an independent prognostic biomarker for end-stage renal disease in ANCA-associated vasculitis: a longitudinal cohort study"],"prefix":"10.1016","volume":"594","author":[{"given":"Fengyun","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiujiao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.cca.2026.122940_bb0005","doi-asserted-by":"crossref","DOI":"10.1007\/s11926-017-0641-0","article-title":"ANCA-associated vasculitis pathogenesis: a commentary","volume":"19","author":"Gapud","year":"2017","journal-title":"Curr. Rheumatol. Rep."},{"key":"10.1016\/j.cca.2026.122940_bb0010","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/402826","article-title":"Pauci-immune crescentic glomerulonephritis: an ANCA-associated vasculitis","author":"Syed","year":"2015","journal-title":"Biomed. Res. Int."},{"issue":"11","key":"10.1016\/j.cca.2026.122940_bb0015","doi-asserted-by":"crossref","first-page":"e771","DOI":"10.1016\/S2665-9913(24)00193-0","article-title":"The effects of age and frailty on the risks of end-stage renal disease, death, and severe infection in older adults with antineutrophil cytoplasmic antibody-associated vasculitis: a retrospective cohort study","volume":"6","author":"Sattui","year":"2024","journal-title":"Lancet Rheumatol"},{"issue":"1","key":"10.1016\/j.cca.2026.122940_bb0020","article-title":"International consensus on ANA patterns (ICAP): the bumpy road towards a consensus on reporting ANA results","volume":"7","author":"Damoiseaux","year":"2016","journal-title":"Autoimmun. Highl."},{"issue":"8","key":"10.1016\/j.cca.2026.122940_bb0025","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1080\/00325481.2025.2602233","article-title":"From antinuclear antibody testing to undifferentiated connective tissue disease diagnosis: a three-year median follow-up of 119 patients","volume":"137","author":"Yarkan Tugsal","year":"2025","journal-title":"Postgrad. Med."},{"issue":"15","key":"10.1016\/j.cca.2026.122940_bb0030","doi-asserted-by":"crossref","DOI":"10.3390\/jcm14155322","article-title":"The art of interpreting antinuclear antibodies (ANAs) in everyday practice","volume":"14","author":"Kadziela","year":"2025","journal-title":"J. Clin. Med."},{"issue":"11","key":"10.1016\/j.cca.2026.122940_bb0035","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1002\/art.1780251101","article-title":"The 1982 revised criteria for the classification of systemic lupus erythematosus","volume":"25","author":"Tan","year":"1982","journal-title":"Arthritis Rheum."},{"issue":"4","key":"10.1016\/j.cca.2026.122940_bb0040","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1002\/art.38994","article-title":"Clinical and immunologic predictors of scleroderma renal crisis in Japanese systemic sclerosis patients with anti-RNA polymerase III autoantibodies","volume":"67","author":"Hamaguchi","year":"2015","journal-title":"Arthritis Rheumatol."},{"issue":"3","key":"10.1016\/j.cca.2026.122940_bb0045","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/BF01409982","article-title":"Autoantibodies and target antigens in antineutrophil cytoplasmic antibody (ANCA)-associated vasculitides","volume":"16","author":"Savige","year":"1996","journal-title":"Rheumatol. Int."},{"issue":"2","key":"10.1016\/j.cca.2026.122940_bb0050","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s00296-020-04704-3","article-title":"Clinical and pathological characteristics of ANA\/anti-dsDNA positive patients with antineutrophil cytoplasmic autoantibody-associated vasculitis","volume":"41","author":"Zhao","year":"2021","journal-title":"Rheumatol. Int."},{"issue":"3","key":"10.1016\/j.cca.2026.122940_bb0055","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1136\/annrheumdis-2021-221795","article-title":"American College of Rheumatology\/European Alliance of associations for rheumatology classification criteria for granulomatosis with polyangiitis","volume":"81","author":"Robson","year":"2022","journal-title":"Ann. Rheum. Dis."},{"issue":"12","key":"10.1016\/j.cca.2026.122940_bb0060","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1136\/ard.2008.101279","article-title":"Modification and validation of the Birmingham Vasculitis activity score (version 3)","volume":"68","author":"Mukhtyar","year":"2009","journal-title":"Ann. Rheum. Dis."},{"issue":"2","key":"10.1016\/j.cca.2026.122940_bb0065","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/art.1780400222","article-title":"Development and initial validation of the Vasculitis damage index for the standardized clinical assessment of damage in the systemic vasculitides","volume":"40","author":"Exley","year":"1997","journal-title":"Arthritis Rheum."},{"issue":"19","key":"10.1016\/j.cca.2026.122940_bb0070","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1056\/NEJMoa2102953","article-title":"New creatinine- and cystatin C-based equations to estimate GFR without race","volume":"385","author":"Inker","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.cca.2026.122940_bb0075","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1681\/ASN.2015060612","article-title":"Mayo Clinic\/Renal Pathology Society consensus report on pathologic classification, diagnosis, and reporting of GN","volume":"27","author":"Sethi","year":"2016","journal-title":"J. Am. Soc. Nephrol."},{"issue":"4","key":"10.1016\/j.cca.2026.122940_bb0080","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1093\/ndt\/gfn586","article-title":"Complement deposition in renal histopathology of patients with ANCA-associated pauci-immune glomerulonephritis","volume":"24","author":"Chen","year":"2009","journal-title":"Nephrol. Dial. Transplant."},{"issue":"10","key":"10.1016\/j.cca.2026.122940_bb0085","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1681\/ASN.2010050477","article-title":"Histopathologic classification of ANCA-associated glomerulonephritis","volume":"21","author":"Berden","year":"2010","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.cca.2026.122940_bb0090","article-title":"End-stage renal disease","author":"Abbasi","year":"2010","journal-title":"BMJ Clin. Evid."},{"issue":"10","key":"10.1016\/j.cca.2026.122940_bb0095","doi-asserted-by":"crossref","first-page":"670","DOI":"10.7326\/0003-4819-150-10-200905190-00004","article-title":"Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized trial","volume":"150","author":"de Groot","year":"2009","journal-title":"Ann. Intern. Med."},{"issue":"3","key":"10.1016\/j.cca.2026.122940_bb0100","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1056\/NEJMoa0909905","article-title":"Rituximab versus cyclophosphamide for ANCA-associated vasculitis","volume":"363","author":"Stone","year":"2010","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.cca.2026.122940_bb0105","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1136\/ard.2010.137778","article-title":"Long-term patient survival in ANCA-associated vasculitis","volume":"70","author":"Flossmann","year":"2011","journal-title":"Ann. Rheum. Dis."},{"issue":"12","key":"10.1016\/j.cca.2026.122940_bb0110","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1093\/ndt\/gfaf120","article-title":"Sex-specific clinical presentations and outcomes in ANCA-associated vasculitis presenting with severe kidney disease","volume":"40","author":"Casal Moura","year":"2025","journal-title":"Nephrol. Dial. Transplant."},{"issue":"1","key":"10.1016\/j.cca.2026.122940_bb0115","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1186\/s13075-018-1752-3","article-title":"The presence of anti-nuclear antibodies alone is associated with changes in B cell activation and T follicular helper cells similar to those in systemic autoimmune rheumatic disease","volume":"20","author":"Baglaenko","year":"2018","journal-title":"Arthritis Res. Ther."},{"issue":"13","key":"10.1016\/j.cca.2026.122940_bb0120","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26136065","article-title":"Immunopathology of Antineutrophil cytoplasmic antibody (ANCA)-associated Vasculitis","volume":"26","author":"Lisowska","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cca.2026.122940_bb0125","article-title":"Glomerular immune deposition in MPO-ANCA associated glomerulonephritis is associated with poor renal survival","volume":"12","author":"Lin","year":"2021","journal-title":"Front. Immunol."},{"issue":"10","key":"10.1016\/j.cca.2026.122940_bb0130","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1097\/PAI.0000000000000134","article-title":"The Clinicopathologic Spectrum of rapidly progressive glomerulonephritis based on glomerular immune deposition and Antineutrophil cytoplasmic antibody","volume":"23","author":"Han","year":"2015","journal-title":"Appl. Immunohistochem. Mol. Morphol."}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898126021224?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898126021224?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T11:30:52Z","timestamp":1793187052000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898126021224"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,3]]},"references-count":26,"alternative-id":["S0009898126021224"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2026.122940","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2027,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Routine antinuclear antibody testing as an independent prognostic biomarker for end-stage renal disease in ANCA-associated vasculitis: a longitudinal cohort study","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2026.122940","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"122940"}}